Skip to main content
SpringerLink
Log in

Interventional cardiology in 2012

We are 'shocked', 'frozen', and 'freed' by new data

  • Year in Review
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

In 2012, results from three studies in interventional cardiology have enhanced our knowledge on the best practices to improve clinical outcomes. These trials were focused on treatment safety as well as efficacy. The optimal therapeutic strategy for patients undergoing percutaneous coronary intervention continues to evolve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thiele, H. et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367, 1287–1296 (2012).

    Article  CAS  Google Scholar 

  2. Collet, J. P. et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N. Engl. J. Med. 367, 2100–2109 (2012).

    Article  CAS  Google Scholar 

  3. Farkouh, M. E. et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 367, 2375–2384 (2012).

    Article  CAS  Google Scholar 

  4. Collet, J. P. et al. Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study. Am. Heart J. 161, 5–12 (2011).

    Article  CAS  Google Scholar 

  5. CURRENT-OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N. Engl. J. Med. 363, 930–942 (2010).

  6. Mehta, S. R. et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 376, 1233–1243 (2010).

    Article  CAS  Google Scholar 

  7. Parodi, G. et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. JAMA 306, 1215–1223 (2011).

    Article  CAS  Google Scholar 

  8. Dewilde, W. & Berg, J. T. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST). Am. Heart J. 158, 713–718 (2009).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author acknowledges Drs Usman Baber and Deb Aranson, The Icahn School of Medicine at Mount Sinai, for their review of the manuscript.

Author information

Authors and Affiliations

  1. The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, 10029, NY, USA

    Roxana Mehran

Authors
  1. Roxana Mehran
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares that she has been a consultant for Abbott Vascular, Astra Zeneca, Bristol-Myers Squibb/Sanofi, Janssen (Johnson & Johnson), Merck, and Regado Biosciences, and has received research grants from Bristol-Myers Squibb/Sanofi, Eli Lilly/Daiichi Sankyo and The Medicines Company.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehran, R. We are 'shocked', 'frozen', and 'freed' by new data. Nat Rev Cardiol 10, 68–70 (2013). https://doi.org/10.1038/nrcardio.2012.200

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2012.200

  • Springer Nature Limited

Search

Navigation